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  15 
Abstract 16 
Yersinia enterocolitica is a zoonotic pathogen and a common cause of 17 
gastroenteritis in humans. The species is composed of 6 diverse phylogroups, of 18 
which phylogroup 1 strains are considered non pathogenic to mammals due to 19 
their lack of the major virulence plasmid pYV and their lack of virulence in a 20 
mouse infection model. Here we present data examining the pathogenicity of 21 
strains of Y. enterocolitica across all six phylogroups in a Galleria mellonellla 22 
model. We show that in this model phylogroup 1 strains exhibit severe 23 
pathogenesis with a lethal dose of as low as 10 cfu. We show that this virulence is 24 
an active process and that flagella play a major role in the virulence phenotype. 25 
Furthermore, we show that the complete lack of virulence in Galleria of the 26 
mammalian pathogenic phylogroups is not due to carriage of the pYV virulence 27 
plasmid. Our data suggest that all Y. enterocolitica can be pathogenic, which may 28 
be a reflection of the true natural habitat of the species and that we may need to 29 
reconsider the eco-evo perspective of this important bacterial species.  30 
Introduction 31 
Yersinia enterocolitica is a member of the Enterobacteriaceae, and a common 32 
cause of gastroenteritis in humans (Bottone, 1999). The majority of human 33 
infections are associated with consumption of, or contamination from, raw and 34 
undercooked pork products (Bottone, 1999; Drummond et al., 2012). Carriage of 35 
Y. enterocolitica is frequently reported in pig tonsil and intestinal tissues 36 
(Martinez et al., 2010; McNally et al., 2004; Milnes et al., 2008) as well as faecal 37 
samples from cattle and sheep (McNally et al., 2004; Milnes et al., 2008). Human 38 
yersiniosis is generally a sporadic infection (Bottone, 1997; Drummond et al., 39 
2012), however it is the third most common cause of bacterial gastroenteritis in 40 
developed countries, behind Campylobacter and Salmonella (McNally et al., 2004; 41 
van Pelt et al., 2003; Rosner et al., 2010). Large outbreaks have also recently 42 
been reported with prolonged epidemic curves (Gierczynski et al., 2009).  43 
Y. enterocolitica is classically typed using a series of biochemical utilisation tests 44 
which separated the species into six distinct biotypes, and further subdivided by 45 
classical serotyping (Bottone, 1999; Wauters et al., 1987). More recently whole 46 
genome sequences and phylogenetic studies have shown that biotypes are not 47 
phylogenetically robust. This has resulted in a proposed a new nomenclature 48 
consisting of phylogroup (PG) 1 (biotype 1A), phylogroup 2 (biotype 1B), 49 
phylogroup 3 (serotype O:3), phylogroup 4 (serotype O5;27), phylogroup 50 
5(serotype O:9), and phylogroup 6 (biotype 5)(Hall et al., 2015; Reuter et al., 51 
2014). PG 1 strains are isolated from a wide range of hosts and habitats and are 52 
considered to be non-pathogenic due to the lack of pathology in a mouse 53 
infection model (Bottone, 1997) and a lack of the major virulence factors found 54 
in Y. enterocolitica (Bottone, 1999). PG 2 strains are considered high-pathogenic 55 
due to lethality in a mouse infection model, whilst PG 3-6 strains are considered 56 
low-pathogenic due to the observed pathology in a mouse infection model 57 
(Bottone, 1999). The major genetic difference between PG 1 and PG 2-6 that 58 
accounts of the differences in observed pathogenesis are the presence of the 59 
virulence plasmid pYV and the adhesion-encoding gene ail in PG 2-6 (Reuter et 60 
al., 2014).  61 
Despite lacking the key virulence factors involved in mammalian pathogenesis, 62 
there is still some debate as to the true pathogenic potential of PG 1 Y. 63 
enterocolitica. The suitability of the mouse infection model has been questioned 64 
as a suitable proxy for human pathogenesis, with different mouse models giving 65 
different levels of observed pathology (Schippers et al., 2008). Epidemiological 66 
studies have isolated PG 1 strains from humans with gastroenteritis (Mallik & 67 
Virdi, 2010; McNally et al., 2004), and experimental studies have shown that PG 68 
1 isolates exhibit the ability to invade cultured epithelial cells (Grant et al., 1999; 69 
McNally et al., 2006; Tennant et al., 2003). PG 1 isolates have also been shown to 70 
survive inside cultured macrophages for longer time-frames than pathogenic PG 71 
2-5 isolates and to trigger a pro-inflammatory response upon macrophages 72 
uptake (McNally et al., 2006). It is known that many PG 1 isolates carry genes 73 
that have been proposed to be Yersinia virulence factors (Kumar & Virdi, 2012; 74 
Singh & Virdi, 2004; Tennant et al., 2005) and population genomic studies have 75 
shown that many genes purported to play a role in Y. enterocolitica pathogenesis 76 
of other PGs are found in PG 1 isolates, and additionally a putative type III 77 
secretion system is found exclusively in PG 1 (Reuter et al., 2014). To date the 78 
only factor that has been shown to be involved in a virulence associated trait in 79 
PG 1 is the requirement of flagella to survive inside macrophages (McNally et al., 80 
2007b).  81 
Here we present data examining the ability of PG 1 Y. enterocolitica to infect the 82 
wax-moth insect larvae Galleria mellonella, a commonly used alternative 83 
infection model for enteropathogens (Gaspar et al., 2009; Senior et al., 2011). 84 
Our data shows that PG 1 isolates exhibit severe virulence in infected Galleria, 85 
with a LD50 of just 10 cfu, and that virulence is enhanced at 25oC compared to 86 
37oC. We also show that the severe virulence of PG 1 isolates is in direct contrast 87 
to mammalian pathogenic PG 2-5 isolates that exhibit almost no virulent 88 
phenotype in Galleria. We also show that mutations in potential virulence genes 89 
previously identified in PG 1 strains show no effect on the Galleria virulence 90 
phenotype, but that the loss of flagella function previously shown to be 91 
necessary for survival in macrophages also attenuates pathogenesis in Galleria. 92 
Therefore the term non-pathogenic should not be applied to PG 1 Y. 93 
enterocolitica given the high levels of entemopathogenesis observed here, and 94 
that a more comprehensive understanding of Y. enterocolitica ecology is required 95 
to fully dissect the lifecycle of this highly diverse bacterial species.  96 
Materials and methods 97 
Bacterial strains and plasmids 98 
A full list of bacterial isolates (Table 1) and plasmids (Table 2) used in this study 99 
is provided. Y. enterocolitica isolates were collected from human, pig, cattle, and 100 
sheep faecal samples (McNally et al., 2004). The isolates investigated in depth in 101 
the study represent comprehensively characterised type strains of each 102 
phylogroup (McNally et al., 2006) and for which a reference genome sequence 103 
has been produced (Reuter et al., 2014). All strains were routinely cultured from 104 
glycerol stocks stored at -80oC using LB agar at 25oC. For all experiments 10 105 
colonies from an agar plate were incubated in 5 ml LB broth at 25oC with shaking 106 
at 200rpm for 18 hours. Strains YE8081, YE1203 and YE14902 had pYV minus 107 
derivative constructed by 2 x 18 hour serial passages on LB agar at 37oC 108 
followed by incubation on CRMOX agar plates at 37oC and selection of large non-109 
pigmented colonies (Farmer et al., 1992). Absence of pYV was confirmed by 110 
Kado and Liu gel electrophoresis (Kado & Liu, 1981) and by PCR using primers 111 
Yscp1 and Yscp2 to detect the YscP gene present on pYV.  112 
Galleria infection assay:  Galleria mellonella were infected as previously 113 
described (Fuchs et al., 2008). Galleria larvae were infected with a series of 114 
bacterial suspensions containing 101, 102, 103 ,104 ,105, 106 , 107 , 108 & 109 cfu of 115 
each Y. enterocolitica strain.  Each dose was injected sub-cutaneously in 10 µl-116 
aliquots into a group of 10 active G. mellonella larvae using a Hamilton syringe. 117 
After injection, each group was placed on a separate 90 mm sterile Petri Dish 118 
containing a 90mm diameter Whatman filter paper.  The injected Galleria groups 119 
were then incubated in the dark at 25°C or 37°C and monitored for a period of 5 120 
days. Ten larvae were injected with a sterile PBS, and 10 were incubated without 121 
any form of injection or treatment. Cessation of movement and changes in larvae 122 
cuticle colour were checked to distinguish dead larvae. All experiments were 123 
repeated in triplicate independently. The LD50 value (the lethal dose required to 124 
kill 50% or more larvae after 5 days incubation) was calculated, and statistical 125 
significance tests were performed using two-sample T-tests.  126 
For experiments enumerating number of bacteria surviving inside Galleria 127 
larvae, individual larvae were sacrificed by incision with a scalpel and then 128 
ground with a sterile mortar and pestle. The material was then resuspended in 129 
10ml sterile PBS and used for bacterial enumeration using CIN Yersinia selective 130 
agar. 131 
Mutagenesis of the cdt and YGT loci 132 
All mutagenesis studies were performed in the genome sequenced type PG 1 133 
strain YE5303 (McNally et al., 2007; Reuter et al., 2014).  A cytolethal distending 134 
toxin (CDT) mutant was made by PCR amplifying cdtB using primers CDTFor and 135 
CDTRev (Table 2) and cloning into pCRTopo2.1 (Invitrogen) to create pAD5. The 136 
cat gene was PCR amplified from pAM6 using primers CmFor and CmRev (Table 137 
2) and cloned into the AgeI site of pAD5. The inactivated cdtB gene was then PCR 138 
amplified and subcloned into the SmaI site of pKNG101. The resulting plasmid 139 
was used to transform E. coli S17-Pir cells, and these were used as donor cells 140 
in a filter mating conjugation with YE5303 (McNally et al., 2007). A functional 141 
Yersinia Genus Type III secretion system (YGT) mutant was constructed by PCR 142 
amplifying the apparatus encoding gene ygtV (Reuter et al., 2014) using primers 143 
ygtvFor and ygtvRev (Table 2) and cloning into pCRTopo2.1 to create pAR1. The 144 
cat gene was PCR amplified from pAM6 using primers CmFor and CmRev and 145 
cloned into an NheI site. The inactivated ygtV gene was then PCR amplified and 146 
subcloned into the SmaI site of pKNG101. The resulting plasmid, pAR3, was used 147 
to transform E. coli S17-Pir cells, and these were used as donor cells in a filter 148 
mating conjugation with YE5303 (McNally et al., 2007). Complementation of the 149 
cdtB and ygtV mutants was performed by transforming the mutated strains with 150 
pAD5 and pAR1 respectively.  151 
Results 152 
Phylogroup 1 Y. enterocolitica show high pathogenicity towards Galleria 153 
mellonella 154 
To determine variation in the pathogenic potential of Y. enterocolitica 155 
phylogroups to G. mellonella, strains YE5303 (PG 1), YE8081 (PG 2), YE1203 (PG 156 
3), YE14902 (PG 4), YE5603 (PG 5) and YE3094/96 (PG 6) were used to 157 
inoculate groups of larvae. Bacteria were pre-grown at 25oC and 37oC prior to 158 
inoculation, and larvae were also incubated at both temperatures post-infection. 159 
The LD50 of each strain in each infection condition was calculated and plotted 160 
(Fig 1, Fig S1). The data clearly shows that YE8081 of PG 2, the highly pathogenic 161 
phylogroup in mouse infection models is the least pathogenic in the Galleria 162 
assay (p = 0.001), and that YE5303 belonging to PG 1, which is considered to be 163 
non-pathogenic to mammalian hosts is the most virulent in all conditions tested 164 
(p < 0.00001) with virulence enhanced at 25oC compared to 37oC, and occurring 165 
when larvae were incubated down to as lows as 15oC (data not shown). The 166 
mammalian low-pathogenic PG 3-6 strains all showed very low levels of 167 
virulence to Galleria, with the exception of the PG 4 strain YE14902. To confirm 168 
the findings a further 23 strains were tested in the Galleria assay (Fig S2) with 169 
bacteria pre-grown at 25oC and the infected Galleria incubated at 37oC, which 170 
show PG 1 strains significantly more virulent in the assay (p = 0.03).  171 
Virulence of PG1 Y. enterocolitica in Galleria is an active process 172 
characterised by rapid death 173 
We sought to determine the kinetics of infection by YE5303 in the Galleria assay. 174 
First we determined the time-to-death for the larvae in all combinations of pre 175 
and post inoculation incubation and doses of bacteria (Fig 2). The results show 176 
that the vast majority of killing occurs rapidly between 10 and 24 hours after 177 
infection, with the exception being doses at or around sub-lethal levels where 178 
small numbers of larvae may die after 24-48 hours. We then took lethal doses (1 179 
x 109 cfu) and sub lethal doses of YE5303, YE1203, YE14902 and YE8081 (1 x 180 
102 cfu, 1x 106 cfu, 1 x 104cfu, and 1 x 107 cfu, respectively) and inoculated 181 
Galleria. At time intervals we sacrificed 5 x larvae in each group and counted the 182 
number of recovered Yersinia from each larva (Fig 3). Our data shows that with 183 
the mammalian pathogenic strains (YE1203, YE14902, and YE8081) the number 184 
of bacteria is unchanged regardless of fate of the larvae. However, in the PG 1 185 
YE5303 the number of bacteria surviving inside the Galleria drops dramatically 186 
in the 24 hours leading to death, whilst in a sub-lethal dose there is rapid and 187 
complete clearance of bacteria. To confirm that the fatal virulence of YE5303 was 188 
an active process we prepared serial dilutions of overnight cultures of YE5303 189 
and then heat killed the cells at 60oC for 1 hour (Autenrieth et al., 1994) before 190 
injecting larvae. No killing of Galleria larvae was observed after injection with 191 
any dose of heat killed bacterial cells.  192 
The Yersinia virulence plasmid pYV does not have a protective effect on 193 
Galleria infection 194 
Given the clear difference in pathogenesis in the Galleria model between pYV 195 
bearing strains and Y. enterocolitica PG 1, we sought to determine if pYV was 196 
involved in the observed non-pathogenic phenotype of PG 2-6 strains. The pYV 197 
plasmid was cured from YE8081, YE1203, and YE14902 by serial culture at 37oC 198 
in the absence of calcium ions, and loss of pYV confirmed by PCR and Kado & Liu 199 
gel electrophoresis. The plasmid + and plasmid – derivatives were then used to 200 
perform larval infections and LD50 compared (Fig 4). The data clearly shows that 201 
the loss of pYV has no impact on the lack of pathogenesis of pYV bearing strains 202 
on Galleria larvae. We also checked the stability of pYV during infections by PCR 203 
amplification performed on bacteria recovered from dead and surviving larvae 204 
(Fig 4). This shows that pYV was stable in all strains except the PG4 strain 205 
YE14902 where 50% (6 of 12 colonies tested by PCR) of tested colonies had lost 206 
the plasmid. PG4 strains curiously are also the most virulent of the pYV bearing 207 
phylogroups in the Galleria assay.  208 
Targeted mutagenesis suggests a role for flagella and intracellular survival 209 
in the pathogenesis of PG1 Y. enterocolitica to Galleria larvae 210 
Comparative analysis of 100 Y. enterocolitica genomes spanning the entire 211 
species diversity identified two putative virulence factors that are unique or 212 
have PG 1 unique alleles (Reuter, et al., 2015). These are the YGT type III 213 
secretion system, and the cytolethal distending toxin CDT. A YGT mutant was 214 
constructed by insertional inactivation of the ygtV apparatus encoding gene, and 215 
a CDT mutant by insertional inactivation of the cdtB gene. We also utilised a 216 
functional flagella mutant made by insertional inactivation of flgB previously 217 
described by our group (McNally et al., 2007). The mutants and complemented 218 
mutants were used to perform Galleria infections and LD50 calculations (Fig 5). 219 
Our data show that mutations in the CDT operon or YGT secretion system have 220 
no discernable effect on virulence of YE5303 in Galleria larvae. However our 221 
previously constructed and characterised flagella mutant has a significant 222 
decrease (p = 0.0014) in virulence compared to the wild type, with restoration of 223 
the phenotype upon complementation with the flgB gene on a high copy number 224 
plasmid.  To test if the lethality may be due to secretion of toxic effectors from 225 
the flagella apparatus we tested the lethality of supernatant from overnight 226 
cultures of YE5303 and the flgB mutant in Galleria larvae. Our results showed 227 
that supernatant from the wild type YE5303 showed 100% mortality (20/20 228 
larvae) whilst supernatant from the flgB mutant showed 10% mortality (2/20 229 
injected larvae).  230 
Discussion 231 
Yersinia enterocolitica is a common causative agent of gastroenteritis in humans 232 
and is a zoonotic infection (Valentin-Weigand, P. Heesemann, J. Dersch, 2014). 233 
Recent population genomic studies have shown that Y. enterocolitica is a highly 234 
diverse species composed of six genetically distinct phylogroups (Hall et al., 235 
2015; Reuter et al., 2014; Reuter et al., 2015). The pathogenic potential of each of 236 
the phylogroups has been well characterised on the basis of epidemiological 237 
studies of human infections (Fredriksson-Ahomaa & Korkeala, 2003; McNally et 238 
al., 2004) as well as the use of mouse models of infection (Handley et al., 2004). 239 
However there is still discordance between such data sets, with a prime example 240 
being the frequent isolation of PG 1 Y. enterocolitica from symptomatic humans 241 
(Mallik & Virdi, 2010; McNally et al., 2004) despite this lineage lacking the 242 
essential pYV virulence plasmid (Reuter et al., 2014) and being completely non-243 
pathogenic in mouse infection models (Schiemann & Devenish, 1982). To further 244 
investigate this dichotomy we utilised the Galleria mellonella infection model as 245 
a novel infection model for representative strain of all Y. enterocolitica 246 
phylogroups. 247 
Our data shows that the PG 1 Y. enterocolitica strains are highly virulent to G. 248 
mellonella larvae with a lethal dose as low as 10 cfu, with virulence enhanced 249 
when the infection is incubated at 25oC compared to 37oC, though there was no 250 
difference if the bacteria were pre-incubated at different temperatures prior to 251 
infection. Conversely, the so called high-pathogenic PG 2 strains showed virtually 252 
no virulence at all using any infection conditions. Additionally, the most 253 
frequently encountered human-pathogenic phylogroups showed only trace 254 
levels of virulence with infectious doses of 107 – 109 cfu. These results appear 255 
counterintuitive and may suggest that G. mellonella is a measure of virulence for 256 
insects, but not for human disease, at least for Y. enterocolitica. 257 
Our data raise more questions on our perceived knowledge of the ecology, life 258 
style and evolution of pathogenesis of the Y. enterocolitica species. Previous 259 
work has shown variation in pathogenesis of the human pathogenic Yersinia 260 
species in insect models of infection (Fuchs et al., 2008) and that insect toxin 261 
genes present in PG 3, 4 and 5 strains of Y. enterocolitica only contribute to 262 
virulence in insects infected via oral ingestion (Fuchs et al., 2008). Our data 263 
clearly shows that PG 1 Y. enteroclitica are acutely pathogenic to Galleria 264 
mellonella via direct sub-cutaneous injection whilst the mammalian pathogenic 265 
phylogroups are not, and it would now be interesting to test PG 1 strains via oral 266 
ingestion by insects as these were not tested in the previous study. The variation 267 
in pathogenesis suggests that different phylogroups are exposed to varying 268 
predation threats, supporting recent population genomic analysis suggesting 269 
that the phylogroups inhabit distinct ecological niches or micro-habitats on the 270 
basis of limited gene sharing (Reuter et al., 2015).  271 
A key difference between PG 1 Y. enterocolitica and the pathogenic phylogroups 272 
is the absence of the pYV virulence plasmid, the major virulence determinant in 273 
mammalian pathogenic Yersinia species (Reuter et al., 2014). The plasmid 274 
contains the Ysc type III secretion system which is known to be used by Yersinia 275 
to disarm macrophages and dendritic cells to allow the bacteria to avoid 276 
phagocytosis (Cornelis & Wolf-Watz, 1997). Given that G. mellonella are known 277 
to contain a functional non-specific immune response it seemed obvious that this 278 
may be the reason for the lack of response of the larvae to the mammalian 279 
pathogenic phylogroups. However our data shows that loss of pYV had no effect 280 
on the virulence of the mammalian pathogenic phylogroups towards the larvae. 281 
Indeed our data shows that the virulence of PG 1 Y. enterocolitica towards G. 282 
mellonella is an active process that requires live cells. Our finding that heat killed 283 
bacterial cells are unable to cause mortality also rule out the possibility that LPS, 284 
which is phylogroup specific in Y. enterocolitica (Reuter, et al., 2015), is the cause 285 
of the severe toxicity of PG 1 strains.  286 
Rather our results show a key role for flagella in the pathogenesis of phylogroup 287 
1 Y. enterocolitica in G. mellonella. Previous work by our group showed that fully 288 
functioning flagella are required for the ability of a PG 1 strain to survive inside 289 
human cultured phagocytic cells for prolonged periods (McNally et al., 2006, 290 
2007a). This suggests that the pathogenesis of PG 1 Y. enterocolitica to G. 291 
mellonella relies upon the ability of bacteria to survive the interaction with 292 
phagocytic cells in the haemoceol (Fuchs et al., 2008). The essential role of 293 
flagella in the G. mellonella virulence process also explains the increased 294 
pathogenesis when infected larvae are incubated at 25oC which is the permissive 295 
temperature for flagella gene expression in Y. enterocolitica (Kapatral et al., 296 
1996). However, the fact that PG 1 strains still show toxicity at 37oC and that the 297 
pre-infection incubation temperature has no effect on toxicity suggests that there 298 
are other underlying molecular mechanisms of both flagella expression 299 
regulation and G. mellonella pathogenesis. Indeed there are no apparent 300 
differences in flagella structure or amino acid sequence between PG 1 and PG 2-5 301 
strains (Reuter et al., 2014; Reuter et al., 2015). This means that the presence of 302 
flagella alone is not sufficient to induce toxicity in the larvae, and that PG 1 Y. 303 
enterocolitica utilise their flagella differently to other lineages of the species. It 304 
may be that PG 1 strains utilise their flagella as a secretion system for lineage 305 
specific effector proteins, something which has previously been proposed in the 306 
species (Schmiel et al., 2000) and is supported by the data showing that 307 
supernatant from wild type PG1 bacteria is lethal to larvae but supernatant from 308 
a flagella mutant is not . Alternatively it may be that there is co-ordinated 309 
interaction between flagella and another as-yet-unidentified system in the 310 
mammalian pathogenic phylogroups that down-regulates the pathogenic 311 
phenotype of the flagella. It is known that there is transcriptional regulation 312 
interplay between flagella and the Ysc secretion system in Y. enterocolitica 313 
(Kapatral & Minnich, 1995), and so it is possible that flagella function is 314 
differentially regulated in each lineage.  315 
We therefore propose that it is no longer accurate to describe PG 1 Y. 316 
enterocolitica as non-pathogenic, and that using an insect infection model we 317 
show that all phylogroups of the Y. enterocolitica are capable of exhibiting high 318 
levels of virulence in selected hosts. This emphasises our need to better 319 
understand the true ecology of each lineage of this important bacterial species. 320 
Furthermore there is now merit to fully investigate the differential functional 321 
roles of flagella in each of the Y. enterocolitica phylogroups, as well as differences 322 
that may exist in their regulatory control.  323 
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Table 1: List of strains used in this study 472 
Strain Name  Phylogroup Biological 
Origin  
Source  
YE8081  PG1  Human  (Thomson et al., 
2006) 
YE0902  PG1 Sheep  (Reuter et al., 2014) 
YE0903  PG1 Human  (Reuter et al., 2014) 
YE3403  PG1 Human  (Reuter et al., 2014) 
YE3503  PG1 Pig  (Reuter et al., 2014) 
YE5303  PG1 Human  (McNally et al., 2006) 
NZ3  PG1 Sheep  (Reuter et al., 2014) 
YE11902  PG5 Sheep  (Reuter et al., 2014) 
YE21202  PG5 Pig  (McNally et al., 2006) 
YE21502  PG5 Pig  (Reuter et al., 2014) 
YE21802  PG5 Pig  (Reuter et al., 2014) 
YE2403  PG5 Human  (Reuter et al., 2014) 
YE5603  PG5 Human  (McNally et al., 2006) 
YE5803  PG5 Human  (Reuter et al., 2014) 
YE11102  PG4 Sheep  (Reuter et al., 2014) 
YE14902  PG4 Sheep  (McNally et al., 2006) 
YE15302  PG4 Cattle  (Reuter et al., 2014) 
YE22602  PG4 Pig  (Reuter et al., 2014) 
YE23102  PG4 Pig  (Reuter et al., 2014) 
YE23202  PG4 Pig  (Reuter et al., 2014) 
YE01/2012  PG3 Human  Claire Jenkins HPA  
YE02/2012  PG3 Human  Claire Jenkins HPA 
YE0303  PG3 Human  (Reuter et al., 2014) 
YE1203 PG3 Human (McNally et al., 2006) 
YE20102 PG3 Pig (Reuter et al., 2014) 
YE20402 PG3 Human (Reuter et al., 2014) 
YE21302 PG3 Pig (Reuter et al., 2014) 
NZ15 PG3 Pig (Reuter et al., 2014) 
Y1 PG3 Human Petra Dersch, HZI) 
YE3094/96 PG6 Hare (Reuter et al., 2014) 
YE5303-
flgBMut 
 YE5303 with 
flgB gene 
inactivated 
(McNally et al., 2007) 
YE5303-
cdtBMut 












  Epicentre UK 
E. coli DH5   Invitrogen UK 
 473 
Table 2: List of primers and plasmids used in this study 474 
Name Description Source 
pCR2.1-TOPO TA cloning vector Invitrogen 
pAR1 pCR2.1 with ygtV inserted This study 
pAM6 pCR2.1 with cat inserted (McNally et al., 2007a) 
pAR2 pAR1 with cat inserted This study 
 
pKNG101 sacB/Pir suicide vector (Kaniga et al., 1991) 
pAR3 pKNG101 with Inactivated 
ygtV from pAR2 inserted 
This study 
pAD5 pCR2.1 with cdtB inserted This study 
pAD6 pAD5 with cat inserted  This study 
pAD9 pKNG101 with inactivated 
cdtB from pAD6 inserted 
This study 
   
cdtFor GGAAATAAATAAATCTGG Tm 530C 
cdtRev GGGTGAGTAGAGTACGGT  
ygtFor GCGCTATATCAGGTAGTTTC Tm 57oC 
ygtRev CGGGAGAATACCGATGAGAG  
CmFor ACCGAGCGTAGCGAGTCAGT Tm 60oC 
CmRev ATTACGCCCCGCCCTGC  
YscP1 ATTAGAACCTGAGTATCAACC Tm 52oC 
YscP2 AACAAATAACTCATCATGTCC  






  480 
Figure 1: The calculated LD50 values for infection of Galleria mellonella of a cross 481 
section of reference Y. entercolitica strains representing the diversity of the 482 
species. Results show values for strains pre-incubated at both 25oC and 37oC 483 
prior to inoculation into larvae. Black bars represent LD50 values for infection at 484 
37oC and grey bars represent values for infection at 25oC. Values are the mean 485 
for three independent experiments and error bars represent the standard error 486 
of the mean.  487 
 488 
Figure 2: Survival curves for Galleria mellonella infected with the phylogroup 1 489 
Y. enterocolitica reference strain 5303. Data shown is a representative 490 
experiment of three independent replicate experiments.  491 
 492 
Figure 3: Infection kinetics graphs showing the numbers of bacteria recovered 493 
from infected Galleria mellonella larvae infected with reference Y. enterocolitica 494 
strains at lethal and sub-lethal doses. Data shown are the mean of three 495 
independent experiments with the error bars indicating the standard error of 496 
the mean.  497 
 498 
Figure 4: (A) The effect of the loss of the pYV virulence plasmid on the 499 
pathogenesis of reference Y. enterocolitica strains to Galleria mellonella. Data 500 
shown are the mean of three independent experiments with the error bars 501 
indicating the standard error of the mean. (B) image showing the stability of pYV 502 
in reference strains of Y. enterocolitica during Galleria mellonella infection, as 503 
determined by PCR detection of the yscP gene. Lane M contains a 100bp marker; 504 
Lanes 1 & 2 show YE8081c 24 hrs and 120 hrs post infection; Lanes 3 & 4 show 505 
12/03 24 hrs and 120 hrs post infection; Lanes 5 and 6 show 212/02 24 hrs & 506 
120 hrs post infection; Lanes 7 & 8 show 149/02 24 hrs & 120 hrs post infection; 507 
Lanes 9 & 10 show 56/03 24 hrs and 120 hrs post infection; Lanes 11 & 12 show 508 
3094/96 24 hrs and 120 hrs post-infection. Lane marked –ve is a no template 509 
negative control.  510 
 511 
Figure 5: Graph showing the effect of mutation and complementation in the CDT 512 
operon (cdtB), the YGT type III secretion system (ygtV), and flagella (flgB) on the 513 
pathogenesis of the phylogroup 1 Y. enterocolitica reference strain 5303. Data 514 
shown are the mean of three independent experiments with the error bars 515 
indicating the standard error of the mean.   516 
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